National Pension Service Has $44 Million Stake in IQVIA Holdings Inc. $IQV

National Pension Service reduced its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 12.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 279,186 shares of the medical research company’s stock after selling 38,752 shares during the period. National Pension Service’s holdings in IQVIA were worth $43,997,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Fairbanks Capital Management Inc. boosted its position in shares of IQVIA by 6.2% during the 2nd quarter. Fairbanks Capital Management Inc. now owns 6,246 shares of the medical research company’s stock valued at $984,000 after purchasing an additional 367 shares in the last quarter. Simplify Asset Management Inc. bought a new position in shares of IQVIA during the 2nd quarter worth approximately $1,251,000. CENTRAL TRUST Co grew its position in shares of IQVIA by 9.5% during the 2nd quarter. CENTRAL TRUST Co now owns 1,205 shares of the medical research company’s stock worth $190,000 after buying an additional 105 shares during the period. Vise Technologies Inc. bought a new stake in shares of IQVIA in the 2nd quarter valued at $286,000. Finally, Allworth Financial LP lifted its position in shares of IQVIA by 43.3% during the 2nd quarter. Allworth Financial LP now owns 970 shares of the medical research company’s stock valued at $153,000 after acquiring an additional 293 shares during the period. 89.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity at IQVIA

In related news, insider Eric Sherbet sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $219.70, for a total transaction of $878,800.00. Following the transaction, the insider directly owned 27,108 shares of the company’s stock, valued at $5,955,627.60. This trade represents a 12.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by corporate insiders.

IQVIA Stock Performance

Shares of IQVIA stock opened at $221.06 on Friday. IQVIA Holdings Inc. has a 52 week low of $134.65 and a 52 week high of $228.12. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 2.03. The business has a 50 day moving average price of $202.72 and a 200-day moving average price of $178.54. The company has a market cap of $37.65 billion, a PE ratio of 30.32, a price-to-earnings-growth ratio of 2.50 and a beta of 1.34.

IQVIA (NYSE:IQV) last announced its quarterly earnings results on Tuesday, October 28th. The medical research company reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.98 by $0.02. The business had revenue of $4.10 billion during the quarter, compared to the consensus estimate of $4.07 billion. IQVIA had a return on equity of 30.70% and a net margin of 8.07%.IQVIA’s revenue was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.84 earnings per share. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. Equities analysts anticipate that IQVIA Holdings Inc. will post 10.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Hsbc Global Res raised shares of IQVIA from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 9th. Mizuho raised their target price on IQVIA from $190.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, July 25th. JPMorgan Chase & Co. upped their price target on IQVIA from $177.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Weiss Ratings reissued a “hold (c)” rating on shares of IQVIA in a research note on Wednesday, October 8th. Finally, Evercore ISI upped their target price on IQVIA from $220.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $241.00.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.